1887

Chapter 59 : Varicella-Zoster Virus

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Varicella-Zoster Virus, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH59-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH59-2.gif

Abstract:

Varicella-zoster virus (VZV) is a readily contagious alphaherpesvirus that commonly causes two distinct exanthematous illnesses. Primary infection with VZV causes varicella, known colloquially as chicken pox, which is characterized by a generalized vesicular rash typically accompanied by fever and other nonspecific symptoms. VZV establishes a lifelong latent infection in the dorsal root ganglia during the first infection, and it can reactivate decades later to cause zoster, also called shingles, a dermatomally distributed and often painful vesicular rash (1, 2). A number of zoster patients present with postherpetic neuralgia, characterized by severe pain that may persist for long periods after the rash has resolved. Some rare complications of zoster include encephalitis, conjunctivitis, keratitis and other eye disorders, Ramsey-Hunt syndrome, neurogenic bladder, and transverse myelitis.

Citation: Schmid D. 2016. Varicella-Zoster Virus, p 556-562. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch59
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818722.ch59
1. Arao Y, Schmid DS, Pellett PE, Inoue N. 1999. Herpesviruses beyond HSV-1 and -2. Clin Microbiol Newsl 21:153160.[CrossRef]
2. Arvin AM, Gilden D,. 2013. Varicella-zoster virus, p 20152057. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields Virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL Shingles Prevention Study Group. 2005. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:22712284.[CrossRef].[PubMed]
4. Marin M, Güris D, Chaves SS, Schmid S, Seward JF Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). 2007. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56(RR-4):140.[PubMed]
5. Bialek SR, Perella D, Zhang J, Mascola L, Viner K, Jackson C, Lopez AS, Watson B, Civen R. 2013. Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics 132:e1134e1140.[CrossRef].[PubMed]
6. Marin M, Watson TL, Chaves SS, Civen R, Watson BM, Zhang JX, Perella D, Mascola L, Seward JF. 2008. Varicella among adults: data from an active surveillance project, 1995–2005. J Infect Dis 197(Suppl 2):S94S100.[CrossRef].[PubMed]
7. Centers for Disease Control and Prevention (CDC). 2004. Outbreak of varicella among vaccinated children—Michigan, 2003. MMWR Morb Mortal Wkly Rep 53:389392.[PubMed]
8. Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL. 2006. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics 117:e1070e1077.[CrossRef].[PubMed]
9. Parker AA, Reynolds MA, Leung J, Anderson M, Rey A, Ortega-Sanchez IR, Schmid DS, Guris D, Gensheimer KF. 2008. Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement—Maine, 2006. J Infect Dis 197(Suppl 2):S101S107.[CrossRef].[PubMed]
10. Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR. 2004. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 113:455459.[PubMed].[CrossRef]
11. Harpaz R, Ortega-Sanchez IR, Seward JF Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). 2008. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57(RR-5):130.[PubMed]
12. Galil K, Mootrey GP, Seward J, Wharton M. 1999. Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 48(RR-6):15.
13. Seward JF, Galil K, Damon I, Norton SA, Rotz L, Schmid S, Harpaz R, Cono J, Marin M, Hutchins S, Chaves SS, McCauley MM. 2004. Development and experience with an algorithm to evaluate suspected smallpox cases in the United States, 2002–2004. Clin Infect Dis 39:14771483.[CrossRef].[PubMed]
14. Hutchins SS, Sulemana I, Heilpern KL, Schaffner W, Wax G, Lerner EB, Watson B, Baltimore R, Waltenburg RA, Aronsky D, Coffin S, Ng G, Craig AS, Behrman A, Meek J, Sherman E, Chavez SS, Harpaz R, Schmid S. 2008. Performance of an algorithm for assessing smallpox risk among patients with rashes that may be confused with smallpox. Clin Infect Dis 46(Suppl 3):S195S203.[CrossRef].[PubMed]
15. Breuer J, Grose C, Norberg P, Tipples G, Schmid DS. 2010. A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24–25 July 2008. J Gen Virol 91:821828.[CrossRef].[PubMed]
16. Loparev VN, Rubtcova EN, Bostik V, Govil D, Birch CJ, Druce JD, Schmid DS, Croxson MC. 2007. Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand. J Virol 81:1275812765.[CrossRef].[PubMed]
17. Zell R, Taudien S, Pfaff F, Wutzler P, Platzer M, Sauerbrei A. 2012. Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination. J Virol 86:16081622.[CrossRef].[PubMed]
18. Barrett-Muir W, Scott FT, Aaby P, John J, Matondo P, Chaudhry QL, Siqueira M, Poulsen A, Yaminishi K, Breuer J. 2003. Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J Med Virol 70(Suppl 1):S42S47.[CrossRef].[PubMed]
19. Loparev VN, Gonzalez A, Deleon-Carnes M, Tipples G, Fickenscher H, Torfason EG, Schmid DS. 2004. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol 78:83498358.[CrossRef].[PubMed]
20. Schmidt-Chanasit J, Sauerbrei A. 2011. Evolution and world-wide distribution of varicella-zoster virus clades. Infect Genet Evol 11:110.[CrossRef].[PubMed]
21. Quinlivan M, Breuer J, Schmid DS. 2011. Molecular studies of the Oka varicella vaccine. Expert Rev Vaccines 10:13211336.[CrossRef].[PubMed]
22. Nahass GT, Goldstein BA, Zhu WY, Serfling U, Penneys NS, Leonardi CL. 1992. Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infection. JAMA 268:25412544.[PubMed].[CrossRef]
23. Bezold GD, Lange ME, Gail H, Peter RU. 2001. Detection of cutaneous varicella zoster virus infections by immunofluorescence versus PCR. Eur J Dermatol 11:108111.[PubMed]
24. Jain S, Wyatt D, McCaughey C, O'Neill HJ, Coyle PV. 2001. Nested multiplex polymerase chain reaction for the diagnosis of cutaneous herpes simplex and herpes zoster infections and a comparison with electron microscopy. J Med Virol 63:5256.[PubMed].[CrossRef]
25. Leung J, Kudish K, Wang C, Moore L, Gacek P, Radford K, Lopez A, Sosa L, Schmid DS, Cartter M, Bialek S. 2010. A 2009 varicella outbreak in a Connecticut residential facility for adults with intellectual disability. J Infect Dis 202:14861491.[CrossRef].[PubMed]
26. Lopez AS, Burnett-Hartman A, Nambiar R, Ritz L, Owens P, Loparev VN, Guris D, Schmid DS. 2008. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 197:646653.[CrossRef].[PubMed]
27. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. 1992. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 66:10161020.[PubMed]
28. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. 2000. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol 38:43154319.[PubMed]
29. Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberkoff MS, Weinberg A, Williams HM, Cheney C, Petrukhin L, Abraham KG, Shaw A, Manoff S, Antonello JM, Green T, Wang Y, Tan C, Keller PM Shingles Prevention Study Group. 2009. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol 81:13101322.[CrossRef].[PubMed]
30. Parker SP, Quinlivan M, Taha Y, Breuer J. 2006. Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J Clin Microbiol 44:39113914.[CrossRef].[PubMed]
31. Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS. 2011. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis 203:316323.[CrossRef].[PubMed]
32. Maple PAC, Gray J, Breuer J, Kafatos G, Parker S, Brown D. 2006. Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin Vaccine Immunol 13:214218.[CrossRef].[PubMed]
33. Maple PAC, Rathod P, Smit E, Gray J, Brown D, Boxall EH. 2009. Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay. J Clin Virol 44:914.[CrossRef].[PubMed]
34. Sauerbrei A, Schäfler A, Hofmann J, Schacke M, Gruhn B, Wutzler P. 2012. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test. Clin Vaccine Immunol 19:12611268.[CrossRef].[PubMed]
35. Behrman A, Schmid DS, Crivaro A, Watson B. 2003. A cluster of primary varicella cases among healthcare workers with false-positive varicella zoster virus titers. Infect Control Hosp Epidemiol 24:202206.[CrossRef].[PubMed]
36. Nandhagopal R, Khmeleva N, Jayakrishnan B, White T, Al Azri F, George J, Heintzman A, Al Zeedy K, Rorke-Adams L, Guijar AR, Schmid DS, Al-Asmi A, Nagel MA, Jacob PC, Gilden D. 2014. Varicella zoster virus pneumonitis and brain stem encephalitis without skin rash in an immunocompetent adult. Open Forum Infect Dis 1:ofu064.[CrossRef].[PubMed]
37. Haug A, Mahalingam R, Cohrs RJ, Schmid DS, Corboy JR, Gilden D. 2010. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: case report and review of the literature. J Neurol Sci 292:8588.[CrossRef].[PubMed]
38. Gilden D, Nagel MA, Cohrs RJ, Mahalingam R. 2013. The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep 13:374.[CrossRef].[PubMed]
39. Lafer MM, Weckx LY, de Moraes-Pinto MI, Garretson A, Steinberg SP, Gershon AA, LaRussa PS. 2011. Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus. Clin Vaccine Immunol 18:11941197.[CrossRef].[PubMed]
40. Asada H, Nagayama K, Okazaki A, Mori Y, Okuno Y, Takao Y, Miyazaki Y, Onishi F, Okeda M, Yano S, Kumihashi H, Gomi Y, Maeda K, Ishikawa T, Iso H, Yamanishi K Shozu Herpes Zoster (SHEZ) Study Group. 2013. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain. J Dermatol Sci 69:243249.[CrossRef].[PubMed]
41. Behrman A, Lopez AS, Chaves SS, Watson BM, Schmid DS. 2013. Varicella immunity in vaccinated healthcare workers. J Clin Virol 57:109114.[CrossRef].[PubMed]
42. Martin KA, Junker AK, Thomas EE, Van Allen MI, Friedman JM. 1994. Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus. J Infect Dis 170:991995.[PubMed].[CrossRef]

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error